Global Retinol-binding Protein Immunoturbidimetric Assay Diagnostic Reagent Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030According to this latest study, the global Retinol-binding Protein Immunoturbidimetric Assay Diagnostic Reagent market size was valued at US$ xx million in 2023 and is forecast to a readjusted size of USD xx million by 2030 with a CAGR of xx% during review period. This report is a detailed and comprehensive analysis for global Retinol-binding Protein Immunoturbidimetric Assay Diagnostic Reagent market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided. Key Features: | USD 3,480.00 |
Global Cell Culture Media Market Research Report 2023The global Cell Culture Media market was valued at US$ 2445 million in 2022 and is anticipated to reach US$ 4630 million by 2029, witnessing a CAGR of 9.48% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Cell Culture Media is estimated to increase from $ 893 million in 2023 to $ 1410 million by 2029, at a CAGR of 7.9% from 2023 through 2029.
Asia-Pacific market for Cell Culture Media is estimated to increase from $ 873 million in 2023 to reach $ 1650 million by 2029, at a CAGR of 11.19% during the forecast period of 2023 through 2029.
The major global manufacturers of Cell Culture Media include Thermo Fisher, Merck, Corning, Cytiva, Lonza, Fujifilm, HiMedia Laboratories, Takara, and Kohjin Bio, etc. In 2022,
... Read more | USD 2,900.00 |
Asia Pacific Next-Generation Ultrasound Systems Market 2022-2031 by Component , Product Type , Technology , Portability , Application, End User, and Country: Trend Forecast and Growth OpportunityAsia Pacific next-generation ultrasound systems market will grow by 10.2% annually with a total addressable market cap of $29,313.0 million over 2023-2031, driven by the mounting prevalence of chronic diseases, the surging demand for high-quality and portable diagnostic tools, the rapid adoption of novel technologies like 3D/4D and AI/IoT, and snowballing healthcare expenditure and government investments to support the R&D activities. Highlighted with 59 tables and 59 figures, this 138-page report “Asia Pacific Next-Generation Ultrasound Systems Market 2022-2031 by Component (Hardware, Software), Product Type (Diagnostic, Therapeutic), Technology (2D, 3D/4D, Others), Portability (Cart/Trolley-Based, Portable, Handheld and Wearables), Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific next-generation ultrasound systems market and all its sub-segments through extensively detailed...Read more | USD 3,200.00 |
Global Genital Herpes Treatment Market 2022-2032 by Virus Type , Drug Type , Route of Administration , Patient Gender , Distribution Channel , and Region: Trend Forecast and Growth OpportunityGlobal genital herpes treatment market will reach $5,051.8 million by 2032, growing by 4.7% annually over 2022-2032, driven by the rising prevalence of sexually transmitted diseases, changing socio-cultural openness, increasing awareness about HSV infection and its symptoms, improved access to antiviral medications, and the government supports. Highlighted with 84 tables and 80 figures, this 168-page report “Global Genital Herpes Treatment Market 2022-2032 by Virus Type (HSV-1, HSV-2), Drug Type (Acyclovir, Valacyclovir, Famciclovir, Others), Route of Administration (Oral, Topical, Injection), Patient Gender (Female, Male), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Stores), and Region: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire global genital herpes treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from...Read more | USD 3,400.00 |
North America Genital Herpes Treatment Market 2022-2032 by Virus Type , Drug Type , Route of Administration , Patient Gender , Distribution Channel , and Country: Trend Forecast and Growth OpportunityNorth America genital herpes treatment market is projected to grow by 3.9% annually in the forecast period and reach $1,650.9 million by 2032, driven by the rising prevalence of sexually transmitted diseases, changing socio-cultural openness, increasing awareness about HSV infection and its symptoms, improved access to antiviral medications, and the government supports. Highlighted with 25 tables and 44 figures, this 107-page report “North America Genital Herpes Treatment Market 2022-2032 by Virus Type (HSV-1, HSV-2), Drug Type (Acyclovir, Valacyclovir, Famciclovir, Others), Route of Administration (Oral, Topical, Injection), Patient Gender (Female, Male), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Stores), and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire North America genital herpes treatment market and all its sub-segments through extensively detailed classifications. Profound...Read more | USD 2,800.00 |